These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. Kumar S; Coenen MJ; Scherer PE; Bahn RS J Clin Endocrinol Metab; 2004 Feb; 89(2):930-5. PubMed ID: 14764816 [TBL] [Abstract][Full Text] [Related]
43. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Ringel J; Engeli S; Distler A; Sharma AM Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859 [TBL] [Abstract][Full Text] [Related]
44. [The molecular mechanisms by which PPAR gamma/RXR inhibitors improve insulin resistance]. Yamauchi T; Kadowaki T Nihon Rinsho; 2001 Nov; 59(11):2245-54. PubMed ID: 11712415 [TBL] [Abstract][Full Text] [Related]
45. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for Type 2 diabetes mellitus in Japanese families? Populaire C; Mori Y; Dina C; Vasseur F; Vaxillaire M; Kadowaki T; Froguel P Diabetologia; 2003 Mar; 46(3):443-5. PubMed ID: 12687348 [No Abstract] [Full Text] [Related]
46. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. Waki H; Yamauchi T; Kamon J; Ito Y; Uchida S; Kita S; Hara K; Hada Y; Vasseur F; Froguel P; Kimura S; Nagai R; Kadowaki T J Biol Chem; 2003 Oct; 278(41):40352-63. PubMed ID: 12878598 [TBL] [Abstract][Full Text] [Related]
48. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Combs TP; Wagner JA; Berger J; Doebber T; Wang WJ; Zhang BB; Tanen M; Berg AH; O'Rahilly S; Savage DB; Chatterjee K; Weiss S; Larson PJ; Gottesdiener KM; Gertz BJ; Charron MJ; Scherer PE; Moller DE Endocrinology; 2002 Mar; 143(3):998-1007. PubMed ID: 11861525 [TBL] [Abstract][Full Text] [Related]
49. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Yatagai T; Nagasaka S; Taniguchi A; Fukushima M; Nakamura T; Kuroe A; Nakai Y; Ishibashi S Metabolism; 2003 Oct; 52(10):1274-8. PubMed ID: 14564678 [TBL] [Abstract][Full Text] [Related]
50. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan. Kuruma S; Egawa N; Kurata M; Honda G; Kamisawa T; Ueda J; Ishii H; Ueno M; Nakao H; Mori M; Matsuo K; Hosono S; Ohkawa S; Wakai K; Nakamura K; Tamakoshi A; Nojima M; Takahashi M; Shimada K; Nishiyama T; Kikuchi S; Lin Y World J Gastroenterol; 2014 Dec; 20(46):17456-62. PubMed ID: 25516658 [TBL] [Abstract][Full Text] [Related]
51. Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance. Gui Y; Silha JV; Mishra S; Murphy LJ Can J Physiol Pharmacol; 2003 Oct; 81(10):979-85. PubMed ID: 14608416 [TBL] [Abstract][Full Text] [Related]
52. Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Gustafson B; Jack MM; Cushman SW; Smith U Biochem Biophys Res Commun; 2003 Sep; 308(4):933-9. PubMed ID: 12927809 [TBL] [Abstract][Full Text] [Related]
53. Drugs, diabetes and pharmacogenomics: the road to personalized therapy. Watanabe RM Pharmacogenomics; 2011 May; 12(5):699-701. PubMed ID: 21619432 [No Abstract] [Full Text] [Related]
54. Precision diabetes: a realistic outlook on a promising approach. Marshall SM Diabetologia; 2017 May; 60(5):766-768. PubMed ID: 28303304 [No Abstract] [Full Text] [Related]
55. Evidence of differing genotypic effects of PPARalpha in women and men. Khan QH; Pontefract DE; Iyengar S; Ye S J Med Genet; 2004 Jun; 41(6):e79. PubMed ID: 15173245 [No Abstract] [Full Text] [Related]
56. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615 [TBL] [Abstract][Full Text] [Related]
57. Clinical worth of adiponectin levels in obesity and glycemic control of Japanese type 2 diabetic patients. Nonogaki K; Kumano H; Ootsuka Y; Takeuchi A; Nonogaki N; Kuboki T Diabetes Care; 2003 Nov; 26(11):3198. PubMed ID: 14578276 [No Abstract] [Full Text] [Related]
58. Adipocytokines and the expanding 'Asian Indian Phenotype'. Mohan V; Deepa R J Assoc Physicians India; 2006 Sep; 54():685-6. PubMed ID: 17212014 [No Abstract] [Full Text] [Related]
59. [Genomics of type 2 diabetes]. Hara K; Kadowaki T Nihon Rinsho; 2002 Aug; 60 Suppl 8():283-9. PubMed ID: 12355760 [No Abstract] [Full Text] [Related]